HEPSERA

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, Spain, UK.

Active ingredients

The drug HEPSERA contains one active pharmaceutical ingredient (API):

1
UNII U6Q8Z01514 - ADEFOVIR DIPIVOXIL
 

Adefovir dipivoxil is an oral prodrug of adefovir, an acyclic nucleotide phosphonate analogue of adenosine monophosphate, which is actively transported into mammalian cells where it is converted by host enzymes to adefovir diphosphate. Adefovir diphosphate inhibits viral polymerases by competing for direct binding with the natural substrate (deoxyadenosine triphosphate) and, after incorporation into viral DNA, causes DNA chain termination.

 
Read more about Adefovir dipivoxil

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 Hepsera 10 mg tablets MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 HEPSERA Tablet MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J05AF08 Adefovir dipivoxil J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Discover more medicines within J05AF08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 510610001115217
CA Health Products and Food Branch 02247823
EE Ravimiamet 1203073, 1295760
ES Centro de información online de medicamentos de la AEMPS 03251001
FI Lääkealan turvallisuus- ja kehittämiskeskus 014510
FR Base de données publique des médicaments 60954219
GB Medicines & Healthcare Products Regulatory Agency 78426
HK Department of Health Drug Office 65358
IE Health Products Regulatory Authority 88503
IL מִשְׂרַד הַבְּרִיאוּת 4714
JP 医薬品医療機器総合機構 6250026F1020
LT Valstybinė vaistų kontrolės tarnyba 1028725, 1028726, 1075653
NL Z-Index G-Standaard, PRK 70629
PL Rejestru Produktów Leczniczych 100127602
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W64757001, W64757002
SG Health Sciences Authority 12341P
US FDA, National Drug Code 61958-0501

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.